基于纳米药物输送系统的瘤免疫调节方面的进展
Bo Wang1, Yue Zhang1, Xunzhe Yin2
1Department of Integrated Chinese and Western Medicine, Jilin Cancer Hospital, Changchun, China.
Frontiers in immunology
|December 18, 2023
概括
纳米药物输送系统通过精确向瘤和调节免疫反应来增强癌症免疫疗法. 这种方法可以增强抗瘤效果,同时最大限度地减少不良反应,为癌症治疗提供了一个有希望的未来.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 免疫疗法有效地针对各种癌症,但由于药物输送不准确和人类的不良反应而面临局限性.
- 纳米药物输送系统提供了一个解决方案,用于精确地将免疫治疗剂输送到目标组织和免疫细胞.
研究的目的:
- 审查用于癌症免疫治疗的纳米药物输送系统的最新进展.
- 讨论纳米药物系统调节瘤微环境和免疫反应的机制.
主要方法:
- 关于瘤免疫治疗中纳米药物输送系统的当前研究的综述.
- 纳米药物机制的分析,包括增强的疫苗吸收,增加瘤免疫性,免疫细胞调节和干扰免疫逃生通路.
主要成果:
- 纳米药物系统提高了树突细胞 (DC) 向和吸收疫苗的速度.
- 这些系统可以增加瘤细胞的免疫性,并调节瘤相关的巨细胞 (TAMs) 和骨髓系衍生抑制细胞.
- 纳米药物干扰关键的免疫逃生通路,如PD-1/PD-L1,FGL1/LAG-3和IDO.
结论:
- 纳米药物输送系统是激活抗瘤免疫反应的可行策略.
- 这些系统对通过瘤免疫调节改善癌症免疫治疗的疗效和安全性具有显著的希望.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


